Upcoming Events All Events

Latest News

MERCK: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A, INC: Konica Minolta Supports the National Kidney Foundation in the Fight Against Kidney Disease

This Sunday, Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) will continue their support of the National Kidney Foundation and the fight against kidney disease by walking in the 2018 New York City Kidney Walk.

CORPORATE ESSENTIALS: Introducing November’s James Beard Award Nominated Chef: Bonnie Morales

Autumn calls for cuisine rich in flavors and seasonings, providing a feeling of comfort on a chilly day.

CELGENE CORPORATION: New Survey Reveals Myelodysplastic Syndromes Leave Patients Feeling Fatigued

While understanding the impact of myelodysplastic syndromes (MDS) on the lives of people diagnosed with these blood cancers can help inform their care, assessments of quality of life in MDS have been, for the most part, lacking.

CELGENE CORPORATION: Celgene Named Among World’s Best Employers 2018

Celgene has long maintained a dual focus on not only the patients that its therapies treat but the employees at Celgene that work to develop those therapies and get them to market.

GREATER ELIZABETH CHAMBER OF COMMERCE: November 7, 2018 | Valenca Bar & Restaurant – Business After Hours

On Wednesday, November 7, mix and mingle with fellow chamber members and explore what the GECC has to offer!

Metro Business Network